跳至主要内容
临床试验/NCT06361680
NCT06361680尚未招募早期 1 期

Efficacy of Coenzyme Q10 Supplementation on Metabolic Control in Children With Type 1 Diabetes Mellitus: a Randomized Clinical Trial

Assiut University0 个研究点目标入组 100 人开始时间: 2024年10月30日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
尚未招募
入组人数
100
主要终点
Assess the effect of Coenzyme Q10 on glycated haemoglobin in type 1 diabetes mellitus

研究概览

简要总结

Determine the effect of Coenzyme Q10 on random blood sugar and glycosylated haemoglobin

详细描述

Type 1 diabetes mellitus is an autoimmune disease that leads to destruction of insulin producing pancreatic Beta cells.

Individuals with type 1 diabetes requires life long insulin replacement with multiple daily insulin injection. daily,insulin pump therapy or the use of an automated insulin delivery system.

without insulin ,diabetic ketoacidosis develops and is life threatening.

In addition to insulin Therapy ,glucose monitoring with a continuous glucose monitor and a blood glucose monitor if continuous glucose monitor is unavailable is recommended .

Coenzyme Q10 supplementation has beneficial effects on glycemic control especially in diabetes , and 100-200 mg per day of Co Q10 could achieve the greatest benefit which could provide a basis for the dietary guidelines of Co Q10 in patients with glycemic disorders .

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Screening
盲法
None

入排标准

年龄范围
2 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • All patients diagnosed as type 1 diabetes mellitus from age of 2 years old to 18 years old with diabetes mellitus of duration at least 1 year.

排除标准

  • - patients diagnosed as diabetes mellitus less than 2 years old .
  • patients with diabetes mellitus of duration less than 1 year.
  • patients diagnosed as type 1 diabetes mellitus with Thyroid or celiac diseases.
  • other types of hyperglycemia rather than Type 1 diabetes mellitus.

研究组 & 干预措施

Group A

Experimental

Will take Coenzyme Q10 soft gel capsules or tablets in a dose of 100-200mg of natural factors

干预措施: Coenzyme Q10 Cap/Tab as natural factors capsules or kirkman tablets (Drug)

Group B

Experimental

Will not take Coenzyme Q10 soft gel capsules or tablets

干预措施: Coenzyme Q10 Cap/Tab as natural factors capsules or kirkman tablets (Drug)

结局指标

主要结局

Assess the effect of Coenzyme Q10 on glycated haemoglobin in type 1 diabetes mellitus

时间窗: One year

This prospective randomized clinical trial will be conducted on 100 participants . Half of them will not receive treatment but group A will receive 100-200mg of Coenzyme Q10 . the level of glycated hemoglobin, fasting blood glucose will be assessed for both groups at baseline and after 3 months of treatment for ongoing use in diabetic children

次要结局

  • Control of random blood sugar and glycated haemoglobin in children with type 1 diabetes mellitus .(One year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Christina Saad Abdel Malak Abdel Nour

Principal Investigator

Assiut University

相似试验